The North America Glycated Albumin Assay Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030).
The glycated albumin assay test can assist in identifying a person's risk for developing complications from the condition and how effectively they manage their diabetes. It is the fructosamine that has been more heavily glycated. It is assessed using a simple and fast enzymatic approach. Glycated albumin testing offers an early and precise evaluation of glycemic management. Glycated albumin readings, instead of glycated hemoglobin, measure long-term glucose levels & show changes in blood sugar levels over the previous two to three weeks. As a result, healthcare providers may optimize diabetes management and lower the risk of complications. This enables rapid intervention and modification of treatment strategies.
The accuracy and dependability of glycated albumin readings will be further enhanced by developing novel technologies & techniques, such as enzymatic and immunoassay-based approaches. Furthermore, incorporating glycated albumin testing with point-of-care devices, digital health platforms, and other related technologies would improve accessibility and practicality for patients and healthcare professionals. The market holds significant promise for improving diabetes management, directing treatment choices, and lowering the risk of complications connected to diabetes as the need for personalized medicine and customized therapies increases. With technological developments and rising clinical usage expected to transform glycemic monitoring and enhance patient outcomes, the future of the market is optimistic.
The 2020 update to the National Diabetes Statistics Report shows that, according to rough estimates for 2018, 10.5% of the US population, or 34.2 million persons of all ages, has diabetes. Thirteen percent of all US adults, or 34.1 million adults over 18, had diabetes. There were 7.3 million adults (18 years and older) who did not know they had diabetes or did not disclose it. These adults met the laboratory criteria for diabetes. 2.8% of US adults and 21.4% of US adults with diabetes are represented by this percentage. With advancing years, the proportion of persons with diabetes rose, reaching 26.8% among those 65 and older. The market is predicted to expand in this region due to the increased prevalence of diabetes.
The US market dominated the North America Glycated Albumin Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $106,249.1 Thousands by 2030. The Canada market is experiencing a CAGR of 10.1% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 9.2% during (2023 - 2030).
Based on Application, the market is segmented into Type 2 Diabetes, Type 1 Diabetes, and Prediabetes. Based on End User, the market is segmented into Hospitals & Diabetic Care Center, Diagnostic Laboratory, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Glycated Albumin Assay Market is Projected to reach USD 384.5 Million by 2030, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), EKF Diagnostics Holdings plc, Weldon Biotech India Private Limited, Hzymes Biotechnology Co., Ltd., Beijing Strong Biotechnologies, Inc., Diazyme Laboratories, Inc. (General Atomics), Abbexa Limited, Biomatik Corporation, Abnova Corporation and Geno Technology, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Type 2 Diabetes
- Type 1 Diabetes
- Prediabetes
By End User
- Hospitals & Diabetic Care Center
- Diagnostic Laboratory
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
- EKF Diagnostics Holdings plc
- Weldon Biotech India Private Limited
- Hzymes Biotechnology Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
- Diazyme Laboratories, Inc. (General Atomics)
- Abbexa Limited
- Biomatik Corporation
- Abnova Corporation
- Geno Technology, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Glycated Albumin Assay Market, by Application
1.4.2 North America Glycated Albumin Assay Market, by End User
1.4.3 North America Glycated Albumin Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. North America Glycated Albumin Assay Market by Application
4.1 North America Type 2 Diabetes Market by Country
4.2 North America Type 1 Diabetes Market by Country
4.3 North America Prediabetes Market by Country
Chapter 5. North America Glycated Albumin Assay Market by End User
5.1 North America Hospitals & Diabetic Care Center Market by Country
5.2 North America Diagnostic Laboratory Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Glycated Albumin Assay Market by Country
6.1 US Glycated Albumin Assay Market
6.1.1 US Glycated Albumin Assay Market by Application
6.1.2 US Glycated Albumin Assay Market by End User
6.2 Canada Glycated Albumin Assay Market
6.2.1 Canada Glycated Albumin Assay Market by Application
6.2.2 Canada Glycated Albumin Assay Market by End User
6.3 Mexico Glycated Albumin Assay Market
6.3.1 Mexico Glycated Albumin Assay Market by Application
6.3.2 Mexico Glycated Albumin Assay Market by End User
6.4 Rest of North America Glycated Albumin Assay Market
6.4.1 Rest of North America Glycated Albumin Assay Market by Application
6.4.2 Rest of North America Glycated Albumin Assay Market by End User
Chapter 7. Company Profiles
7.1 Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
7.1.1 Company Overview
7.1.2 SWOT Analysis
7.1.3 Financial Analysis
7.1.4 Segmental and Regional Analysis
7.1.5 Research & Development Expenses
7.2 EKF Diagnostics Holdings plc
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Weldon Biotech India Private Limited
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 Hzymes Biotechnology Co., Ltd.
7.4.1 Company Overview
7.5 Beijing Strong Biotechnologies, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Abbexa Limited
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Biomatik Corporation
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Abnova Corporation
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Geno Technology, Inc.
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Diazyme Laboratories, Inc. (General Atomics)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.3 SWOT Analysis
TABLE 1 North America Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 2 North America Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 3 North America Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 4 North America Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 5 North America Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 6 North America Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 7 North America Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 8 North America Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 9 North America Prediabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 10 North America Prediabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 11 North America Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 12 North America Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 13 North America Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
TABLE 14 North America Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
TABLE 15 North America Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
TABLE 16 North America Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
TABLE 17 North America Others Market by Country, 2019 - 2022, USD Thousands
TABLE 18 North America Others Market by Country, 2023 - 2030, USD Thousands
TABLE 19 North America Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
TABLE 20 North America Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
TABLE 21 US Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 22 US Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 23 US Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 24 US Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 25 US Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 26 US Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 27 Canada Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 28 Canada Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 29 Canada Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 30 Canada Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 31 Canada Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 32 Canada Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 33 Mexico Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 34 Mexico Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 35 Mexico Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 36 Mexico Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 37 Mexico Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 38 Mexico Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 39 Rest of North America Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 40 Rest of North America Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 41 Rest of North America Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 42 Rest of North America Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 43 Rest of North America Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 44 Rest of North America Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 45 Key Information – Asahi Kasei Pharma Corporation
TABLE 46 Key Information – EKF Diagnostics Holdings plc
TABLE 47 Key Information – Weldon Biotech India Private Limited
TABLE 48 Key Information – Hzymes Biotechnology Co., Ltd.
TABLE 49 Key Information – Beijing Strong Biotechnologies, Inc.
TABLE 50 Key Information – Abbexa Limited
TABLE 51 Key Information – Biomatik Corporation
TABLE 52 Key Information – Abnova Corporation
TABLE 53 Key Information – Geno Technology, Inc.
TABLE 54 Key Information – Diazyme Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Glycated Albumin Assay Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Glycated Albumin Assay Market
FIG 4 Porter’s Five Forces Analysis – Glycated Albumin Assay Market
FIG 5 North America Glycated Albumin Assay Market share by Application, 2022
FIG 6 North America Glycated Albumin Assay Market share by Application, 2030
FIG 7 North America Glycated Albumin Assay Market by Application, 2019 - 2030, USD Thousands
FIG 8 North America Glycated Albumin Assay Market share by End User, 2022
FIG 9 North America Glycated Albumin Assay Market share by End User, 2030
FIG 10 North America Glycated Albumin Assay Market by End User, 2019 - 2030, USD Thousands
FIG 11 North America Glycated Albumin Assay Market share by Country, 2022
FIG 12 North America Glycated Albumin Assay Market share by Country, 2030
FIG 13 North America Glycated Albumin Assay Market by Country, 2019 - 2030, USD Thousands
FIG 14 SWOT Analysis: Asahi Kasei Pharma Corporation
FIG 15 SWOT Analysis: EKF Diagnostics Holdings plc
FIG 16 SWOT Analysis: Weldon Biotech India Private Limited
FIG 17 SWOT Analysis: Beijing Strong Biotechnologies, Inc.
FIG 18 SWOT Analysis: Abbexa Limited
FIG 19 SWOT Analysis: Biomatik Corporation
FIG 20 SWOT Analysis: Abnova Corporation
FIG 21 SWOT Analysis: Geno Technology, Inc.
FIG 22 SWOT Analysis: Diazyme Laboratories, Inc.